1h Free Analyst Time
The NGS-based RNA-seq market is forecasted to grow by USD 6.65 billion during 2023-2028, accelerating at a CAGR of 20.52% during the forecast period. The report on the NGS-based RNA-seq market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased adoption of next generation sequencing methods, technological advancement in sequencing platforms, and availability of wide range of next generation sequencing products.
The NGS-based RNA-seq market is segmented as below:
By End-user
- Acamedic and research centers
- Clinical research
- Pharma companies
- Hospitals
By Technology
- Sequencing by synthesis
- Ion semiconductor sequencing
- Single-molecule real-time sequencing
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the NGS-based RNA-seq market covers the following areas:
- NGS-based RNA-seq market sizing
- NGS-based RNA-seq market forecast
- NGS-based RNA-seq market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Technology
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the NGS-Based RNA-Seq market: Agilent Technologies Inc., Azenta Inc., BGI Genomics Co. Ltd., DNASTAR Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Hamilton Co., Illumina Inc., Pacific Biosciences of California Inc., Perkin Elmer Inc., PierianDx Inc., Precigen Inc., Psomagen Inc., QIAGEN NV, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Zymo Research Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advances in next-generation sequencing techniques."
According to the report, one of the major drivers for this market is the increased adoption of next generation sequencing methods.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Azenta Inc.
- BGI Genomics Co. Ltd.
- DNASTAR Inc.
- Eurofins Scientific SE
- F. Hoffmann La Roche Ltd.
- Hamilton Co.
- Illumina Inc.
- Pacific Biosciences of California Inc.
- Perkin Elmer Inc.
- PierianDx Inc.
- Precigen Inc.
- Psomagen Inc.
- QIAGEN NV
- Takara Bio Inc.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- Zymo Research Corp.
